Xiuning Le: Key Questions in EGFR PACC-Mutant Lung Cancer at the Winter Lung Cancer Conference

Xiuning Le, Associate Professor, Deputy Section Chief of Thoracic Medical Oncology at MD Anderson Cancer Center, shared a post on X by Edgardo Santos, Medical Director of Broward County, Florida at The Oncology Institute of Hope and Innovation and Vice President of the Florida Society of Clinical Oncology, adding:

“For EGFR PACC mutation lung cancer, novel TKIs are under active investigation. The next key questions are:

1. Single vs. compound PACC mutations
2. co-mutation’s impact on treatment
3. tumor immune microenvironment difference
4. strategies for overcoming resistance.

Thank you, PER, WinterLung26, Edgardo S. Santos, and Mark Socinski, for providing this dynamic discussion platform.”

Quoting Edgardo Santos’ post:

“Outstanding presentation by Prof Xiuning Le from MDACC on EGFR PACC mutation; the importance of identifying and reporting them and the new clinical trials in this space. Here at the 23rd WLC.”

More posts featuring Xiuning Le.